Palvella Therapeutics, Inc. (PVLA)
92.08
-1.84
(-1.96%)
USD |
NASDAQ |
Jan 22, 16:00
92.52
+0.44
(+0.48%)
After-Hours: 07:22
Palvella Therapeutics EPS Diluted (Quarterly): -1.025 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Ligand Pharmaceuticals, Inc. | 5.685 |
| Pelthos Therapeutics, Inc. | -5.304 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.34M |
| Total Expenses (Quarterly) | 11.34M |
| Enterprise Value | 1.042B |
| Earnings Yield | -7.13% |
| Normalized Earnings Yield | -6.815 |